|
Status |
Public on Jun 26, 2017 |
Title |
RNA-seq of primary patient AML samples |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The goals of this study are to compare transcriptome profiling (RNA-seq) of patients BM with or without ASXL2 mutations.
|
|
|
Overall design |
Patient bone marrow mRNA profiles with or without ASXL1/2 mutations were generated by deep sequencing
|
|
|
Contributor(s) |
Sinha AU |
Citation(s) |
28516957 |
|
Submission date |
Jul 13, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Omar Abdel-Wahab |
E-mail(s) |
abdelwao@mskcc.org
|
Organization name |
Memorial Sloan Kettering Cancer Center
|
Department |
Medicine
|
Lab |
Omar Abdel-Wahab Lab
|
Street address |
1275 York Ave.
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (16)
|
|
This SubSeries is part of SuperSeries: |
GSE84365 |
RNA-seq and ChIP-seq data of ASXL1/2 in Hematopoiesis |
|
Relations |
BioProject |
PRJNA328993 |
SRA |
SRP078441 |